TrialPloS one2013

Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.

Jenny M Kreahling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.